Direct naar (in deze pagina):inhoud, zoeken of menu.

U bevindt zich op: Home vaccinaties Literatuur


  1. Leerboek infectieziekten1992: Bohn Stafleu Van Loghum.
  2. Handboek vaccinaties; infectieziekten en vaccinaties. eerste ed. Vol. deel B. 2007.
  3. Epidemiology and Prevention of Vaccine-Preventable Diseases_course textbook_chapter on measles, CDC, Editor 2012.
  4. Mitchell, P., et al., Previous vaccination modifies both the clinical disease and immunological features in children with measles. J Prim Health Care, 2013. 5(2): p. 93-8.
  5. Waaijenborg, S., et al., Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage. J Infect Dis, 2013.
  6. Mollema, L., et al., High risk of a large measles outbreak despite thirty years of measles vaccination in the Netherlands. submitted, 2013.
  7. Miller, E., et al., Bacterial infections, immune overload, and MMR vaccine. Measles, mumps, and rubella. Arch Dis Child, 2003. 88(3): p. 222-3.
  8. Peltola, H. and O.P. Heinonen, Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet, 1986. 1(8487): p. 939-42.
  9. Starr, S. and S. Berkovich, Effects of Measles, Gamma-Globulin-Modified Measles and Vaccine Measles on the Tuberculin Test. N Engl J Med, 1964. 270: p. 386-91.
  10. Wesley, A., H.M. Coovadia, and L. Henderson, Immunological recovery after measles. Clin Exp Immunol, 1978. 32(3): p. 540-4.
  11. D'Angio, C.T., Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability. Paediatr Drugs, 2007. 9(1): p. 17-32.
  12. Bonhoeffer, J., C.A. Siegrist, and P.T. Heath, Immunisation of premature infants. Arch Dis Child, 2006. 91(11): p. 929-35.
  13. Saari, T.N., Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics, 2003. 112(1 Pt 1): p. 193-8.
  14. Koblin, B.A., et al., Response of preterm infants to diphtheria-tetanus-pertussis vaccine. Pediatr Infect Dis J, 1988. 7(10): p. 704-11.
  15. Offit, P.A. and R.K. Jew, Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics, 2003. 112(6 Pt 1): p. 1394-7.
  16. Handboek vaccinaties; theorie en uitvoeringspraktijk. tweede ed2011.
  17. David, S., P.E. Vermeer-de Bondt, and N.A. van der Maas, Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands. Vaccine, 2008. 26(46): p. 5883-7
  18. Vermeer-de Bondt, P.E., et al., Adverse events following immunization under the National Vaccination Programme of the Netherlands. Number XVII-reports in 2010, 2011, National Institute for Public Health and the Environment: Bilthoven.
  19. Andrews, N., et al., A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark. Vaccine, 2012. 30(19): p. 3042-6.
  20. Kroesbergen, H.T., L. Moret-Huffmeijer, and P.E. Vermeer-de Bondt, Verschijnselen na gelijktijdige BMR- en meningokokken-C vaccinatie. Tijdschrift voor Sociale geneeskunde, 2005. 83(7): p. 425-431.
  21. Stowe, J., et al., Idiopathic thrombocytopenic purpura and the second dose of MMR. Arch Dis Child, 2008. 93(2): p. 182-3.
  22. Heijstek, M.W., et al., Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA, 2013. 309(23): p. 2449-56.
  23. Andersen, D.V. and I.M. Jorgensen, MMR vaccination of children with egg allergy is safe. Dan Med J, 2013. 60(2): p. A4573.
  24. Godlee, F., J. Smith, and H. Marcovitch, Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ, 2011. 342: p. c7452.
  25. Madsen, K.M., et al., A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med, 2002. 347(19): p. 1477-82.
  26. DeStefano, F., Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther, 2007. 82(6): p. 756-9.
  27. Davis, R.L. and K. Bohlke, Measles vaccination and inflammatory bowel disease: controversy laid to rest? Drug Saf, 2001. 24(13): p. 939-46.
  28. Davis, R.L., et al., Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med, 2001. 155(3): p. 354-9.
  29. Demicheli, V., et al., Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev, 2012. 2: p. CD004407.
  30. Rumke, H.C. and H.K. Visser, [Childhood vaccinations anno 2004. II. The real and presumed side effects of vaccination]. Ned Tijdschr Geneeskd, 2004. 148(8): p. 364-71.

Laatst gewijzigd januari 2015